Chenghao Chu

764 total citations · 1 hit paper
18 papers, 269 citations indexed

About

Chenghao Chu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Statistics and Probability. According to data from OpenAlex, Chenghao Chu has authored 18 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 4 papers in Statistics and Probability. Recurrent topics in Chenghao Chu's work include Cystic Fibrosis Research Advances (4 papers), Statistical Methods in Clinical Trials (4 papers) and Pregnancy and preeclampsia studies (2 papers). Chenghao Chu is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Statistical Methods in Clinical Trials (4 papers) and Pregnancy and preeclampsia studies (2 papers). Chenghao Chu collaborates with scholars based in United States, Ireland and Canada. Chenghao Chu's co-authors include Neil Ahluwalia, Shufang Liu, Alan Rong, Tanya G. Weinstock, Jonathan H. Rayment, Elizabeth Tullis, Mengdi Lu, Edward F. McKone, Anna Chin and Jennifer L. Taylor‐Cousar and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Pain and American Journal of Physiology-Cell Physiology.

In The Last Decade

Chenghao Chu

15 papers receiving 266 citations

Hit Papers

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaft... 2023 2026 2024 2025 2023 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenghao Chu United States 9 133 30 25 22 22 18 269
Michael Nolde Germany 10 35 0.3× 32 1.1× 9 0.4× 7 0.3× 5 0.2× 33 282
Jenny X. Sun United States 9 55 0.4× 33 1.1× 13 0.5× 12 0.5× 10 0.5× 9 451
J-P Collet Canada 7 117 0.9× 23 0.8× 4 0.2× 22 1.0× 7 0.3× 7 365
Zhaoxin Qian China 8 58 0.4× 44 1.5× 22 0.9× 36 1.6× 37 295
Candace Carter Australia 7 58 0.4× 21 0.7× 43 1.7× 13 0.6× 5 0.2× 12 269
Janice Hansen Australia 9 185 1.4× 30 1.0× 31 1.2× 7 0.3× 5 0.2× 19 330
Ebru Gök Oğuz Türkiye 11 42 0.3× 35 1.2× 14 0.6× 11 0.5× 42 261
Frank Glover United States 10 123 0.9× 64 2.1× 24 1.0× 18 0.8× 32 377
M Chan China 9 128 1.0× 30 1.0× 10 0.4× 23 1.0× 12 298
Wanting Zhai United States 9 55 0.4× 12 0.4× 32 1.3× 17 0.8× 18 209

Countries citing papers authored by Chenghao Chu

Since Specialization
Citations

This map shows the geographic impact of Chenghao Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghao Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghao Chu more than expected).

Fields of papers citing papers by Chenghao Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghao Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghao Chu. The network helps show where Chenghao Chu may publish in the future.

Co-authorship network of co-authors of Chenghao Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghao Chu. A scholar is included among the top collaborators of Chenghao Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghao Chu. Chenghao Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wainwright, Claire, Susanna A. McColley, Paul McNally, et al.. (2025). Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension Study. American Journal of Respiratory and Critical Care Medicine. 211(10). 1915–1925. 1 indexed citations
2.
Chu, Chenghao, et al.. (2024). MEF2A restrains cisplatin resistance in gastric cancer cells by modulating NFKBIA/NF-κB signaling pathway. Journal of Investigative Medicine. 73(1). 54–66. 1 indexed citations
3.
Chu, Chenghao, et al.. (2023). Identification and development of TP53 mutation-associated Long non-coding RNAs signature for optimized prognosis assessment and treatment selection in hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. 37. 1200431891–1200431891.
4.
Goralski, Jennifer L., Jordana E. Hoppe, Marcus Mall, et al.. (2023). Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele. American Journal of Respiratory and Critical Care Medicine. 208(1). 59–67. 74 indexed citations breakdown →
5.
Wainwright, Claire, Susanna A. McColley, Paul McNally, et al.. (2023). Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 208(1). 68–78. 34 indexed citations
6.
Huang, Cheng, Chenghao Chu, Yimeng Lu, Bingming Yi, & Ming‐Hui Chen. (2023). Bayesian Interim Analysis in Basket Trials. 54–71.
7.
Ramsey, Bonnie W., Christoph U. Correll, David R. DeMaso, et al.. (2023). Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events. American Journal of Respiratory and Critical Care Medicine. 209(3). 299–306. 26 indexed citations
8.
Chu, Chenghao & Bingming Yi. (2021). Dynamic Historical Data Borrowing Using Weighted Average. Journal of the Royal Statistical Society Series C (Applied Statistics). 70(5). 1259–1280. 1 indexed citations
9.
Chu, Chenghao, Shufang Liu, & Alan Rong. (2020). Study design of single‐arm phase II immunotherapy trials with long‐term survivors and random delayed treatment effect. Pharmaceutical Statistics. 19(4). 358–369. 4 indexed citations
10.
Hirsh, Adam T., Megan Miller, Nicole A. Hollingshead, et al.. (2019). A randomized controlled trial testing a virtual perspective-taking intervention to reduce race and socioeconomic status disparities in pain care. Pain. 160(10). 2229–2240. 45 indexed citations
11.
Varberg, Kaela M., et al.. (2018). Transgelin Induces Dysfunction of Fetal Endothelial Colony-Forming Cells From Gestational Diabetic Pregnancies. PMC. 1 indexed citations
12.
Liu, Shufang, Chenghao Chu, & Alan Rong. (2018). Weighted log‐rank test for time‐to‐event data in immunotherapy trials with random delayed treatment effect and cure rate. Pharmaceutical Statistics. 17(5). 541–554. 19 indexed citations
13.
Varberg, Kaela M., et al.. (2018). Transgelin induces dysfunction of fetal endothelial colony-forming cells from gestational diabetic pregnancies. American Journal of Physiology-Cell Physiology. 315(4). C502–C515. 19 indexed citations
14.
Varberg, Kaela M., Seth Winfree, Chenghao Chu, et al.. (2017). Kinetic analyses of vasculogenesis inform mechanistic studies. PMC.
15.
Chen, Dongming, Jun Dong, Ying Huang, et al.. (2017). Folate metabolism genetic polymorphisms and meningioma and glioma susceptibility in adults. Oncotarget. 8(34). 57265–57277. 5 indexed citations
16.
Varberg, Kaela M., Seth Winfree, Chenghao Chu, et al.. (2017). Kinetic analyses of vasculogenesis inform mechanistic studies. American Journal of Physiology-Cell Physiology. 312(4). C446–C458. 9 indexed citations
17.
Tu, Wanzhu, Chenghao Chu, Shanshan Li, & Suthat Liangpunsakul. (2016). Development and Validation of a Composite Score for Excessive Alcohol Use Screening. Journal of Investigative Medicine. 64(5). 1006–1011. 8 indexed citations
18.
Ge, Jin‐Fang, et al.. (2015). Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization. Endocrine Journal. 62(10). 927–938. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026